| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate |
2006-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2014-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101362993-B1 |
| titleOfInvention |
Stimulants of activated factor VII (FFA) as novel topical anti-bleeding agents |
| abstract |
The activated coagulation factor X (FXa) stimulant of the invention can be used for the treatment of bleeding in any subject. Compounds and combinations that are particularly useful for topical treatment of bleeding in healthy subjects or patients with hemorrhagic specific constitutions have been described. |
| priorityDate |
2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |